Literature DB >> 5313526

Coagulation abnormalities in cystic fibrosis.

D M Komp, R F Selden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5313526     DOI: 10.1378/chest.58.5.501

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  7 in total

1.  PIVKA-II concentrations in patients with cystic fibrosis.

Authors:  E A Cornelissen; A F van Lieburg; C G van Oostrom; L Monnens
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

Review 2.  A rational approach to the nutritional care of patients with cystic fibrosis.

Authors:  P R Durie; P B Pencharz
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

3.  Plasma vitamin K1 concentrations in cystic fibrosis.

Authors:  I A Choonara; M J Winn; B K Park; J M Littlewood
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

Review 4.  Cystic fibrosis.

Authors:  M R Bye; J M Ewig; L M Quittell
Journal:  Lung       Date:  1994       Impact factor: 2.584

Review 5.  Vitamin K and the management of patients with cystic fibrosis.

Authors:  P R Durie
Journal:  CMAJ       Date:  1994-10-01       Impact factor: 8.262

6.  Machine learning to predict progression of non-alcoholic fatty liver to non-alcoholic steatohepatitis or fibrosis.

Authors:  Sina Ghandian; Rahul Thapa; Anurag Garikipati; Gina Barnes; Abigail Green-Saxena; Jacob Calvert; Qingqing Mao; Ritankar Das
Journal:  JGH Open       Date:  2022-03-08

Review 7.  Hematologic and oncologic complications in the critically ill child.

Authors:  S McIntosh
Journal:  Yale J Biol Med       Date:  1984 Mar-Apr
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.